Clinical outcomes of a genomic screening program for actionable genetic conditions
Open Access
- 30 June 2020
- journal article
- research article
- Published by Elsevier BV in Genetics in Medicine
- Vol. 22 (11), 1874-1882
- https://doi.org/10.1038/s41436-020-0876-4
Abstract
No abstract availableThis publication has 32 references indexed in Scilit:
- Population-Based Screening forBRCA1andBRCA2JAMA, 2014
- Population-based screening for breast and ovarian cancer risk due to BRCA1 and BRCA2Proceedings of the National Academy of Sciences of the United States of America, 2014
- Revisiting the pathogenesis of ovarian cancer: the central role of the fallopian tubeArchiv für Gynäkologie, 2013
- Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: Consensus Statement of the European Atherosclerosis SocietyEuropean Heart Journal, 2013
- Modes of delivery of genetic testing services and the uptake of cancer risk management strategies in BRCA1 and BRCA2 carriersClinical Genetics, 2013
- Familial Hypercholesterolemia: Screening, diagnosis and management of pediatric and adult patients: Clinical guidance from the National Lipid Association Expert Panel on Familial HypercholesterolemiaJournal of Clinical Lipidology, 2011
- Familial Hypercholesterolemia: Screening, diagnosis and management of pediatric and adult patientsJournal of Clinical Lipidology, 2011
- The Search for Unaffected Individuals with Lynch Syndrome: Do the Ends Justify the Means?Cancer Prevention Research, 2011
- Revisting wilson and Jungner in the genomic age: a review of screening criteria over the past 40 yearsBulletin of the World Health Organization, 2008
- Genetic Causes of Monogenic Heterozygous Familial Hypercholesterolemia: A HuGE Prevalence ReviewAmerican Journal of Epidemiology, 2004